Language Mapping in Patients With Epilepsy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00706160|
Recruitment Status : Completed
First Posted : June 27, 2008
Last Update Posted : November 11, 2019
This study will examine how certain language skills, such as naming objects, understanding spoken language and reading are organized in the brain and how they are affected by seizures.
People with epilepsy who are considering surgery and healthy volunteers who are right-handed and between the ages of 7 and 55 may be eligible for this study. Participants undergo the following procedures twice, and, in some cases, possibly three times, in two or three visits of 2 to 4 hours each.
Neuropsychological tests: Testing includes questionnaires, pen-and-pencil or computerized tests and motor tasks.
Structural MRI: This procedure uses a strong magnetic field and radio waves to obtain pictures of brain structure. During the test, the subject lies in the scanner (a metal cylinder surrounded by a magnetic field) for about 90 minutes, wearing earmuffs to muffle knocking noises the machine makes. Subjects may be asked to lie still for up to 10 minutes at a time.
Functional MRI: This procedure is similar to structural MRI, except a coil is placed over the head and the subject performs simple tasks during the procedure. The pictures obtained show what parts of the brain are being used to perform the task. The test lasts about 60 minutes, with subjects asked to lie still for up to 10 minutes at a time.
Magnetoencephalography (MEG) and electroencephalography (EEG): For MEG, the subject sits in an MEG recording room with a cone containing magnetic field detectors lowered onto his or her head. Very small magnetic changes produced by the activity of the brain are recorded while the subject sits quietly or performs a research task. An EEG recording of the electrical activity of the brain is done at the same time as the MEG.
|Condition or disease|
|Epilepsy Epilepsy, Temporal Lobe Partial Epilepsy|
Objective: This protocol will test the hypothesis that successful left hemisphere epilepsy surgery for children and adults improves abnormalities in the functional anatomy of language that may be associated with uncontrolled localization-related seizures. We will use an established modality, functional magnetic resonance imaging (fMRI), which has been used extensively for evaluation of patients with epilepsy, as our primary outcome measure, and an emerging modality, magnetoencephalography (MEG), as a secondary measure. We will explore methods of MEG data analysis for comparison with fMRI results.
150 patients with localization-related epilepsy who are surgical candidates and 50 healthy volunteers.
Design: This is a non-invasive imaging study that will employ a test battery including standard neuropsychological tests, structural MRI, fMRI, and a 275-channel whole-head MEG recording, for evaluation of the functional anatomy of language. The test battery will be performed pre-operatively and at 12 months after surgery.
Main outcome measure: Measurement of the "laterality index" comparing left and right hemisphere regional activation on fMRI before and after surgery, in patients after left sided or right-sided surgery, and healthy controls.
Secondary outcome measure: Measurement of the "laterality index" comparing left and right hemisphere regional activation on MEG before and after surgery.
|Study Type :||Observational|
|Actual Enrollment :||153 participants|
|Official Title:||Noninvasive Language Mapping in Patients With Localization-Related Epilepsy|
|Study Start Date :||June 13, 2008|
|Study Completion Date :||April 4, 2013|
- Change in asymmetry index of fMRI after surgery.
- Changes in asymmetry index on MEG after surgery and seizure control after surgery.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00706160
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|
|Principal Investigator:||William H Theodore, M.D.||National Institute of Neurological Disorders and Stroke (NINDS)|